New HIV-seq tool advances understanding of persistent viral reservoirs
For people living with human immunodeficiency virus (HIV), life-saving antiretroviral therapy keeps their HIV-infected immune cells from making…
HIV can develop resistance to lenacapavir, but at a cost to the virus
 Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game…
Expanded HIV treatment dramatically reduced orphanhood rates in Uganda
The scale-up of HIV treatment and prevention programs has led to remarkable declines in orphanhood rates in Rakai,…
Tryptophan deficiency in breast milk may explain health challenges in children born to mothers with HIV
A new UCLA study reveals that breast milk from women living with HIV contains significantly lower levels of…
HIV protein Tat found to increase vulnerability to tuberculosis
According to the World Health Organization, tuberculosis accounts for one in three deaths among people living with HIV.…